Vasomotor System
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ZK283197 for Treatment of Vasomotor Symptoms (NCT00537836) | Bayer | 2007-10-01 |
| Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women (NCT00369434) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-06-01 |
Track Vasomotor System automatically
Every clearance here is in the API, with alerts when new ones post.